Table 2.
Patient characteristics by GOG protocol (N = 420). Summarized the similarity of clinicopathologic characteristics of the patients that received IP chemotherapy under GOG 114 and those in the IP arm of GOG 172.
| GOG 114 | GOG 172 | p value | |
|---|---|---|---|
| Age years | 48.3 57.1 64.7 | 49.3 57.3 65.2 | 0.305 |
| BMI kg/m2 | 21.5 24.1 28.4 | 21.6 24.8 28.6 | 0.676 |
| Race/Ethnicity | |||
| White | 91% (202) | 91% (182) | 0.062 |
| Black | 6% (13) | 3% (6) | |
| Performance status | |||
| 0 | 46% (100) | 100% (200) | <0.001 |
| 1 | 45% (99) | 0% (0) | |
| Grade (differentiation) | 0.641 | ||
| good | 10.5% (23) | 12.5% (25) | |
| moderate | 40.5% (89) | 35.0% (70) | |
| poor | 48.2% (106) | 51.0% (102) | |
| Histology | 0.002 | ||
| serous adenocarcinoma | 63% (139) | 77.0% (154) | |
| endometrioid adenocarcinoma | 14.5% (32) | 8.5% (17) | |
| mixed epithelial carcinoma | 9.5% (21) | 6.5% (13) | |
| clear-cell carcinoma | 3.2% (7) | 5.5% (11) | |
| Gross residual disease | 0.296 | ||
| no | 34% (75) | 39% (78) | |
| yes | 66% (145) | 61% (122) | |
| Surgical interval days | 70 83 93 | 19 26 36 | <0.001 |
| No. complete IP cycles | 4 6 6 | 1 4 6 | <0.001 |
a b c represent the lower quartile a, the median b, and the upper quartile c for continuous variables.
N is the number of non–missing values.
Numbers after percents are frequencies.
Tests used: 1Wilcoxon test; 2Pearson test